TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - MERCK & CO. Stock

Certificat

DE000SF5JH52

Delayed Deutsche Boerse AG 07:12:20 2024-06-18 EDT
4.37 EUR +3.07% Intraday chart for TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - MERCK & CO.
Current month+7.61%
1 month-5.78%
Date Price Change
24-06-18 4.37 +3.07%
24-06-17 4.24 -2.97%
24-06-14 4.37 +0.23%
24-06-13 4.36 -2.02%
24-06-12 4.45 -3.26%

Delayed Quote Deutsche Boerse AG

Last update June 18, 2024 at 07:12 am

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer Société Générale Société Générale
WKN SF5JH5
ISINDE000SF5JH52
Date issued 2021-10-07
Strike 82.46 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.87
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 4.74
Lowest since issue 0.039
Spread 0.06
Spread %1.35%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
127.5 USD
Average target price
142.7 USD
Spread / Average Target
+11.91%
Consensus